Robinson-Hamm, Jacqueline N.
Gersbach, Charles A.
Funding for this research was provided by:
Muscular Dystrophy Association (MDA277360)
National Institutes of Health (R01AR069085, DP2-OD008586)
Medical Research and Materiel Command (W81XWH-15-1-0469)
Article History
Received: 7 July 2016
Accepted: 8 August 2016
First Online: 20 August 2016
Compliance with ethical standards
:
: CA.G. and J.R.H. have filed patent applications related to genome editing for Duchenne muscular dystrophy. C.A.G. is an advisor to Editas Medicine, a company engaged in development of therapeutic genome editing.